Related Experiment Video
Updated: Sep 8, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
[Cardiopulmonary exercise testing in the management of systemic sclerosis]
1Service de Médecine Interne, Centre Hospitalier Universitaire de Nice, Hôpital l'Archet 1, Nice, France; Université Côte d'Azur, Nice, France; CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire, 54831, équipe: génome non-codant et pathologies pulmonaires, Valbonne, France; Inserm U1065, Centre Méditerranéen de Médecine Moléculaire, équipe: contrôle de l'expression génique, Nice, France..
Abstract:
Cardiopulmonary complications are the leading cause of mortality in patients with systemic sclerosis (SSc) requiring an early identification. A global and comprehensive approach is needed due to the complexity of the overlapping aetiologies of dyspnoea in SSc. Through its integrative approach of ventilatory, metabolic, cardiovascular, skeletal muscular and gas exchange findings, cardiopulmonary exercise testing (CPET) has been known to identify and sort competing mechanisms of exercise limitation in scleroderma patients presenting with dyspnoea. CPET may be used to screen for pulmonary arterial hypertension, suspect interstitial lung disease and guide therapeutic strategies including exercise rehabilitation. This review focuses on the clinical value of CPET in the decision-making processes for a more personalised diagnostic approach to SSc-related complications.
Related Concept Videos
Cardiomyopathy VI: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Cardiomyopathy IV: Restrictive Cardiomyopathy
COPD: Management Using Bronchodilators and Corticosteroids
Cardiomyopathy V: Interprofessional Care

